• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOS SPLENDOR X ALEX + ND:YAG; FAMILY OF SQUARE EPIL (ALEX, ALEX2, ND:YAG, ALEX+ND:YAG),PRODUCT CODE: GEX

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOS SPLENDOR X ALEX + ND:YAG; FAMILY OF SQUARE EPIL (ALEX, ALEX2, ND:YAG, ALEX+ND:YAG),PRODUCT CODE: GEX Back to Search Results
Model Number SPLENDOR X ALEX + ND:YAG
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Burn(s) (1757); Insufficient Information (4580)
Date of Event 10/13/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Lumenis investigated the reported event by contacting the user facility directly.Attempts by emails and phone calls have been made to obtain, patient treatment settings, patient information, patient photo.Service engineer tested the device and advised: "10/16 verified power calibration for alex and yag wavelengths, cleaned focus tip optics, found damaged cooling line from the zimmer to the hp.Ordered new cooling line.10/17 replaced the cooling line connecting the zimmer chiller to the hand piece.System meets specifications and is ready for use." manufacturer representative advised: "in my opinion this malfunction cannot lead to serious injuries.When the shots become "hot", well before developing serious burns, a rational and conscious patient asks to stop the treatment.In order the incident to become serious, the patient should withstand repeated shots on the same spot, willingly ignoring pain.So i would rate this event non-reportable." however, since the customer didn't provide us clinical data, this case will be submitted to the fda clinically wise in an 'abundance of caution'.Since no essential information was received within period which is determined for reportability, lumenis is reporting this event in an 'abundance of caution'.Should additional significant information become available, the complaint record will be updated accordingly and a follow-up medwatch report will be submitted.Since lumenis is not the legal manufacturer of the device, this case is non-reportable by lumenis.Nevertheless, all the information of this adverse event was sent to the legal manufacturer "bios".
 
Event or Problem Description
Lumenis received an adverse event report on a patient who sustained injury following treatment by spx device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPLENDOR X ALEX + ND:YAG
Common Device Name
FAMILY OF SQUARE EPIL (ALEX, ALEX2, ND:YAG, ALEX+ND:YAG),PRODUCT CODE: GEX
Manufacturer (Section D)
BIOS
s.r.l. via guido rossa 10/12
vimodrone (mi) 20090, it, 20090
IT  20090
MDR Report Key18099415
Report Number3020611964-2023-00015
Device Sequence Number7717537
Product Code GEX
UDI-Device Identifier08052049500067
UDI-Public08052049500067
Combination Product (Y/N)N
Initial Reporter StateIL
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Importer
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 11/09/2023
Report Date (Section F) 11/09/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Other
Device Model NumberSPLENDOR X ALEX + ND:YAG
Device Catalogue NumberGA-5000000
Was Device Available for Evaluation? Yes
Was the Report Sent to FDA? Yes
Distributor Facility Aware Date10/13/2023
Device Age2 MO
Event Location Hospital
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date11/09/2023
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexPrefer Not To Disclose
Patient EthnicityNon Hispanic
Date Report Sent to FDA11/09/2023
-
-